Literature DB >> 14515110

The Pediatric Economic Database Evaluation (PEDE) Project: establishing a database to study trends in pediatric economic evaluation.

Wendy J Ungar1, Maria T Santos.   

Abstract

BACKGROUND: While standard methods for conducting economic evaluations have evolved, little attention has been paid to the conduct of these studies in special populations such as children.
OBJECTIVES: To build a database of pediatric economic evaluations and to examine trends in publication characteristics over a 20-year period. RESEARCH
DESIGN: The database was created through a multisource search strategy, manual review, application of inclusion/exclusion criteria, data extraction, and reliability assessment. Descriptive statistics were used to summarize trends in publication volume, disease category, intervention type, and age group between 1980 and 1999.
RESULTS: From an initial cut of 5600 citations identified from 12 journal databases, 787 were included as full pediatric economic evaluations. Volume of publications increased 7-fold between 1980 to 1984 and 1995 to 1999 from 61 to 440 citations per 5-year period. Most studies were performed in children aged 1 to 12 years, and studies in infants displayed an increasing frequency. The most common disease category was infective/parasitic, comprising 24% of studies. Studies of congenital anomalies and complications of pregnancy were also prominent. Although health prevention studies were the most prevalent, health treatment studies demonstrated an equal frequency in 1995 to 1999. Most studies consisted of malaria control and vaccination strategies for hepatitis B, Haemophilus influenzae type B, measles, and varicella.
CONCLUSIONS: The number of pediatric economic evaluations is steadily increasing with most publications representing health prevention interventions. The Pediatric Economic Database Evaluation (PEDE) Project database will be valuable to health researchers working in methods research and conducting systematic reviews.

Entities:  

Mesh:

Year:  2003        PMID: 14515110     DOI: 10.1097/01.MLR.0000088451.56688.65

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

Review 1.  Trends in paediatric health economic evaluation: 1980 to 1999.

Authors:  W J Ungar; M T Santos
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

2.  Assessing the evidence for the use of chiropractic manipulation in paediatric health conditions: A systematic review.

Authors:  Allan Gotlib; Ron Rupert
Journal:  Paediatr Child Health       Date:  2005-03       Impact factor: 2.253

3.  Characteristics and quality of pediatric cost-utility analyses.

Authors:  Seija K Kromm; Jennifer Bethell; Ferne Kraglund; Sarah A Edwards; Audrey Laporte; Peter C Coyte; Wendy J Ungar
Journal:  Qual Life Res       Date:  2011-10-29       Impact factor: 4.147

Review 4.  The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review.

Authors:  Filipa Sampaio; Inna Feldman; Tara A Lavelle; Norbert Skokauskas
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-03-09       Impact factor: 4.785

Review 5.  Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.

Authors:  Joseph A Ladapo; Peter J Neumann; Ron Keren; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 6.  Generic preference-based health-related quality of life in children with neurodevelopmental disorders: a scoping review.

Authors:  Ramesh Lamsal; Brittany Finlay; David G T Whitehurst; Jennifer D Zwicker
Journal:  Dev Med Child Neurol       Date:  2019-06-21       Impact factor: 5.449

7.  Development of a pharmacoeconomic registry: an example using hormonal contraceptives.

Authors:  Annesha White; Meenakshi Srinivasan; La Marcus Wingate; Samuel Peasah; Marc Fleming
Journal:  Health Econ Rev       Date:  2021-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.